RE:RE:RE:RE:RE:I personally believe that MERCK will be the company that---With the talk of one major drug company acquiring Theralase, I totally disagree there will be one offer only and only one to consider. With what appears to be the best cancer treatment ever researched don’t expect an early sellout and expect possibly a frenzy of bids to acquire it when it becomes clear that the treatment works and the company is available. $52.00 will be very small compared to the buyout number. IMO. Also a discussed senario is a combination of buyers picking up a total percentage not above the total of that held by Theralase, giving Theralase remaining control. I can only imagine those wanting portion of the shares paying a large price tag too. Another senario is 2 or more large drug companies teaming up to buy Theralase due to the huge cost to acquire. Again, in my humble amateur opinion.